1/39
Looks like no tags are added yet.
Dose-Response Curve
A graph showing that for most drugs, the magnitude of pharmacologic response is proportionately related to the (log of) drug concentration at the tissue (receptor) site — "as you give more drug, you get more response"
Phase 1 of Dose-Response Curve
No response observed at low drug concentrations
Phase 2 of Dose-Response Curve
Linear response with desired effect; ideal dosing regimen results in plasma drug concentrations (PDC) that fall within this therapeutic range
Phase 3 of Dose-Response Curve
No increased response seen despite higher doses; toxic effects become possible
ED50
Effective Dose in 50% of a population
TD50
Toxic Dose in 50% of a population
LD50
Lethal Dose in 50% of a population
Therapeutic Index
The ratio of TD50 to ED50 (TD50/ED50); provides an indication of drug safety — the larger (wider) the index, the safer the drug
Wide Therapeutic Index
A large separation between the effective dose curve and the toxic dose curve, indicating a safer drug
Narrow Therapeutic Index
A small separation between the effective dose curve and the toxic dose curve, indicating a less safe drug requiring careful dosing
Pharmacodynamics (mechanism)
How drugs produce effects in the body via biochemical/physiologic changes; the drug binds to a receptor, causing a change in physical property of the cell or chemical/metabolic changes — drugs do NOT create new cell effects/actions
Drug Receptor
A protein on or within the cell surface/cytoplasm that a ligand binds to in order to produce an effect
Ligand
Something that binds a receptor; can be an endogenous signal molecule or a drug
Ion Channel Receptor
A ligand-gated receptor type that opens or closes an ion channel upon agonist binding, leading to activation of conductance
GPCR (G-Protein Coupled Receptor)
A receptor type that, upon agonist binding, activates a G-protein, generating a second messenger and activating cell signaling
Enzyme-Linked Receptor (Receptor Tyrosine Kinase)
A receptor type where agonist binding causes phosphorylation of tyrosines on key signaling molecules, activating cell signaling (e.g., Tyrosine Kinase)
Intracellular Hormone Receptor
A receptor type where the agonist is transported to the nucleus, activating transcription and translation
Receptor Upregulation/Downregulation
An adaptive mechanism where receptor number or sensitivity changes, which may affect clinical response, especially with chronic drug exposure
Tachyphylaxis
"Acute tolerance" — a rapidly decreasing response to a drug after only a few doses
Tolerance
A decreasing response to repeated constant doses of a drug; may be pharmacokinetic or pharmacodynamic in nature (terms often used interchangeably); accounts for why a drug may stop working over time
Affinity
The force of attraction between a drug and its receptor; higher affinity drugs are harder to displace from the receptor
Selectivity
The specificity of a drug for its target receptor binding (e.g., alpha 1/2, beta 1/2, dopamine 1/2 receptors); important because it produces stronger effects on the target receptor and fewer side effects on unwanted receptors
Potency
A comparative term describing the concentration of different drugs necessary to induce the same magnitude of response; a more potent drug is NOT necessarily a better drug — potency and clinical superiority are different concepts
EC50
The concentration of a drug required to produce 50% of its maximal response; used to compare potency between drugs (lower EC50 = higher potency)
Efficacy (Intrinsic Activity)
The ability of a drug to produce a response upon binding a receptor; a complex relationship involving drug concentration, receptor activation, and cellular response
Agonist
A drug that binds to a receptor and activates it, causing a response; based on occupation theory, where the magnitude of response is proportional to the number of receptors occupied
Full Agonist
A drug that binds to a receptor and produces the maximal possible biological response
Partial Agonist
A drug that binds to and activates a receptor but only produces a partial response; maximal response is not observed (lower efficacy) even at full receptor occupancy
Antagonist
A drug that interacts selectively with receptors but lacks intrinsic efficacy; it blocks or reduces the action of an agonist at the receptor, producing no effect of its own
Inverse Agonist
A drug that binds a receptor with constitutive (baseline) activity and produces a "negative" response, reducing activity below the receptor's basal level (e.g., some H2-receptor drugs)
Neutral Antagonist
A drug that binds a receptor without altering its baseline (constitutive) activity, simply blocking other ligands from binding
Competitive Antagonist
Binds weakly (reversibly) to the same receptor site as the agonist; the inhibitory effect CAN be reversed by increasing the dose of the agonist, since both compete for the same binding site
Noncompetitive Antagonist
Binds strongly to the same receptor site (irreversibly) or allosterically at a different site; the inhibitory effect CANNOT be reversed by increasing the dose of the agonist
Reversible Antagonist Binding
Binding via weak bonds (H-bonds, van der Waals forces) that can be displaced when agonist concentration increases; results in decreased potency but same maximal efficacy
Irreversible Antagonist Binding
Binding via strong bonds (e.g., covalent bonds) that cannot be broken/displaced even with more agonist; results in decreased maximal efficacy, even at higher agonist doses
Chemical Antagonism
A type of antagonism involving direct chemical interaction between two drugs (e.g., a weak acid and a weak base neutralizing each other)
Physiologic Antagonism
Two drugs act in the same physiologic system but on different receptors or pathways, producing opposing effects
Pharmacokinetic Antagonism
One drug alters the response to another drug through changes in its disposition (absorption, distribution, metabolism, or excretion)
Drug Characteristics Affecting Receptor Concentration
Factors including molecular weight (smaller = more transfer), lipid solubility (higher = more transfer), pKa (unionized = more transfer), protein binding (lower = more transfer), and concentration gradient (higher = more transfer)
Requirements for Pharmacodynamic Effect
Drugs must reach the receptor to have an effect, which requires good pharmacokinetics and certain physicochemical properties of the drug